Vericel Corp
Develops autologous cell therapies for sports medicine and severe burn care markets.
VCEL | US
Overview
Corporate Details
- ISIN(s):
- US92346J1088
- LEI:
- Country:
- United States of America
- Address:
- 64 SIDNEY ST., 2139 CAMBRIDGE
- Website:
- https://vcel.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Vericel Corporation is a commercial-stage biopharmaceutical company that develops, manufactures, and commercializes advanced cell therapies. Specializing in autologous treatments, the company uses a patient's own cells to repair damaged tissues. Its key markets include sports medicine and severe burn care. Vericel's portfolio features two proprietary cell therapy products for these applications. The company also holds exclusive North American commercial rights to NexoBrid®, a biological product approved for eschar removal in severe thermal burns.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Vericel Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Vericel Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Vericel Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
